PUBLISHER: TechNavio | PRODUCT CODE: 2172602
PUBLISHER: TechNavio | PRODUCT CODE: 2172602
Global Influenza Vaccine Market 2026-2030
The global influenza vaccine market is forecasted to grow by USD 4410.0 mn during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The report on the global influenza vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding government immunization and public health preparedness initiatives, rising geriatric population and influenza complication burden, advancements in vaccine technologies and product innovation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.8% |
| CAGR | 8.2% |
| Incremental Value | $4410.0 mn |
Technavio's global influenza vaccine market is segmented as below:
By Distribution Channel
- Hospitals and pharmacies
- Government and institutional
- Others
By Type
- LAIV
- RIV
By Age Group
- Adult
- Geriatric
- Pediatric
By Route Of Administration
- Intramuscular (IM) injection
- Intranasal spray
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the increasing integration of combination respiratory immunization approaches as one of the prime reasons driving the global influenza vaccine market growth during the next few years. Also, growing emphasis on diversified vaccine platform portfolios and expansion of data-driven influenza surveillance and forecasting networks will lead to sizable demand in the market.
The report on the global influenza vaccine market covers the following areas:
- Global influenza vaccine market sizing
- Global influenza vaccine market forecast
- Global influenza vaccine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global influenza vaccine market vendors that include Abbott Laboratories, AstraZeneca Plc, Bharat Biotech Ltd., Cadila Pharmaceuticals Ltd., Changchun BaiKe Biotechnology Co, CSL Seqirus USA Inc., Daiichi Sankyo Co. Ltd., GC Biopharma Corp., GlaxoSmithKline Plc, Hualan Biological Engineering Inc, KM Biologics Co. Ltd., Moderna Inc., Sanofi SA, Serum Institute of India Ltd., Sinovac Biotech Ltd., SK Bioscience, Viatris Inc., Zydus Lifesciences Ltd.. Also, the global influenza vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Influenza Vaccine Market 2020 - 2024
- Historic Market Size - Data Table on Global Influenza Vaccine Market 2020 - 2024 ($ million)
- 5.2 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 Age Group segment analysis 2020 - 2024
- Historic Market Size - Age Group Segment 2020 - 2024 ($ million)
- 5.5 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- 5.6 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.7 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global influenza vaccine market
- 6.2 Impact of geopolitical conflicts on global influenza vaccine market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Distribution Channel
- 8.1 Market segments
- 8.2 Comparison by Distribution Channel
- 8.3 Hospitals and pharmacies - Market size and forecast 2025-2030
- 8.4 Government and institutional - Market size and forecast 2025-2030
- 8.5 Others - Market size and forecast 2025-2030
- 8.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 LAIV - Market size and forecast 2025-2030
- 9.4 RIV - Market size and forecast 2025-2030
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by Age Group
- 10.1 Market segments
- 10.2 Comparison by Age Group
- 10.3 Adult - Market size and forecast 2025-2030
- 10.4 Geriatric - Market size and forecast 2025-2030
- 10.5 Pediatric - Market size and forecast 2025-2030
- 10.6 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
11 Market Segmentation by Route of Administration
- 11.1 Market segments
- 11.2 Comparison by Route of Administration
- 11.3 Intramuscular (IM) injection - Market size and forecast 2025-2030
- 11.4 Intranasal spray - Market size and forecast 2025-2030
- 11.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- 13.2 Geographic comparison
- 13.3 North America - Market size and forecast 2025-2030
- 13.3.1 US - Market size and forecast 2025-2030
- 13.3.2 Canada - Market size and forecast 2025-2030
- 13.3.3 Mexico - Market size and forecast 2025-2030
- 13.4 Europe - Market size and forecast 2025-2030
- 13.4.1 Germany - Market size and forecast 2025-2030
- 13.4.2 UK - Market size and forecast 2025-2030
- 13.4.3 France - Market size and forecast 2025-2030
- 13.4.4 Italy - Market size and forecast 2025-2030
- 13.4.5 Spain - Market size and forecast 2025-2030
- 13.4.6 The Netherlands - Market size and forecast 2025-2030
- 13.5 Asia - Market size and forecast 2025-2030
- 13.5.1 China - Market size and forecast 2025-2030
- 13.5.2 Japan - Market size and forecast 2025-2030
- 13.5.3 India - Market size and forecast 2025-2030
- 13.5.4 South Korea - Market size and forecast 2025-2030
- 13.5.5 Indonesia - Market size and forecast 2025-2030
- 13.5.6 Taiwan - Market size and forecast 2025-2030
- 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 13.6.1 Brazil - Market size and forecast 2025-2030
- 13.6.2 Australia - Market size and forecast 2025-2030
- 13.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 13.6.4 South Africa - Market size and forecast 2025-2030
- 13.6.5 UAE - Market size and forecast 2025-2030
- 13.6.6 Argentina - Market size and forecast 2025-2030
- 13.6.7 Israel - Market size and forecast 2025-2030
- 13.6.8 Chile - Market size and forecast 2025-2030
- 13.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
- 14.1 Market drivers
- Expanding government immunization and public health preparedness initiatives
- Rising geriatric population and influenza complication burden
- Advancements in vaccine technologies and product innovation
- 14.2 Market challenges
- Challenges in strain prediction and vaccine effectiveness
- High manufacturing complexity and cold-chain management requirements
- Uneven vaccination access and adoption across populations
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 14.4 Market opportunities
- Increasing integration of combination respiratory immunization approaches
- Growing emphasis on diversified vaccine platform portfolios
- Expansion of data-driven influenza surveillance and forecasting networks
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- Companies covered
- 16.2 Company ranking index
- Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- 16.6 Bharat Biotech Ltd.
- Bharat Biotech Ltd. - Overview
- Bharat Biotech Ltd. - Product / Service
- Bharat Biotech Ltd. - Key offerings
- SWOT
- 16.7 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- 16.8 Changchun BaiKe Biotechnology Co
- Changchun BaiKe Biotechnology Co - Overview
- Changchun BaiKe Biotechnology Co - Product / Service
- Changchun BaiKe Biotechnology Co - Key offerings
- SWOT
- 16.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Business segments
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
- Daiichi Sankyo Co. Ltd. - Segment focus
- SWOT
- 16.10 GC Biopharma Corp.
- GC Biopharma Corp. - Overview
- GC Biopharma Corp. - Business segments
- GC Biopharma Corp. - Key offerings
- GC Biopharma Corp. - Segment focus
- SWOT
- 16.11 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 16.12 Hualan Biological Engineering Inc
- Hualan Biological Engineering Inc - Overview
- Hualan Biological Engineering Inc - Business segments
- Hualan Biological Engineering Inc - Key offerings
- Hualan Biological Engineering Inc - Segment focus
- SWOT
- 16.13 Moderna Inc.
- Moderna Inc. - Overview
- Moderna Inc. - Product / Service
- Moderna Inc. - Key offerings
- SWOT
- 16.14 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 16.15 Sinovac Biotech Ltd.
- Sinovac Biotech Ltd. - Overview
- Sinovac Biotech Ltd. - Product / Service
- Sinovac Biotech Ltd. - Key offerings
- SWOT
- 16.16 SK Bioscience
- SK Bioscience - Overview
- SK Bioscience - Product / Service
- SK Bioscience - Key offerings
- SWOT
- 16.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
- 16.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- Research methodology
- 17.5 Data procurement
- Information sources
- 17.6 Data validation
- Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
- List of abbreviations
